BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 19 filers reported holding BIOPHARMX CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $59,000 | -59.0% | 671,686 | -50.0% | 0.00% | – |
Q4 2018 | $144,000 | +13.4% | 1,343,372 | +100.0% | 0.00% | – |
Q3 2018 | $127,000 | -14.2% | 671,686 | 0.0% | 0.00% | – |
Q2 2018 | $148,000 | -4.5% | 671,686 | 0.0% | 0.00% | – |
Q1 2018 | $155,000 | +342.9% | 671,686 | +107.3% | 0.00% | – |
Q4 2017 | $35,000 | -62.0% | 323,967 | 0.0% | 0.00% | – |
Q3 2017 | $92,000 | -40.6% | 323,967 | 0.0% | 0.00% | – |
Q2 2017 | $155,000 | +1837.5% | 323,967 | +1775.5% | 0.00% | – |
Q1 2017 | $8,000 | – | 17,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 16,128,515 | $3,561,000 | 0.46% |
Virtu Financial LLC | 580,070 | $128,000 | 0.01% |
FRG Family Wealth Advisors LLC | 30,000 | $7,000 | 0.00% |
FRANKLIN RESOURCES INC | 9,749,615 | $2,153,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $148,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 16,779 | $4,000 | 0.00% |
OPPENHEIMER & CO INC | 35,000 | $8,000 | 0.00% |
CREDIT SUISSE AG/ | 50,003 | $11,000 | 0.00% |
MORGAN STANLEY | 100 | $0 | 0.00% |
Invesco Ltd. | 51,964 | $11,000 | 0.00% |